Viewing Study NCT07416032


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-30 @ 12:07 AM
Study NCT ID: NCT07416032
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-17
First Post: 2026-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: QH-WH-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View